| |
| |
SPOT ON
|
| |
Who buys whom? When big pharma goes shopping …
|
| |
| |
THERAPY FROM A CRITICAL VIEWPOINT
|
| |
Endocarditis prophylaxis: from rule to exception
|
| |
| |
a-t READER'S QUESTIONS AND COMMENTS
|
| |
ACE inhibitors plus angiotensin II receptor antagonists: a reasonable combination?
Levothyroxine (e.g. EUTHYROX) in the morning or at night?
|
| |
| |
QUALITY CONTROL
|
| |
Quality comparison of bisoprolol (CONCOR, generics) tablets as well as lisinopril (ACERBON, generics) tablets
|
| |
| |
IN BRIEF
|
| |
Do proton pump inhibitors attenuate the effectiveness of acetylsalicylic acid?
Mefloquine (LARIAM) no longer for emergency self-treatment of malaria
EMA - oral preparations of the vasodilatator buflomedil (FUFEDIL, generics) should be withdrawn from the market
Umbrella brands: what is FENISTIL - an antiallergic, a corticoid, a virostatic or a medical device?
|
| |
| |
BEWARE! MISSINFORMATION
|
| |
Freeloader: promotion of PERENTEROL
|
| |
| |
SIDE EFFECTS
|
 |
Hearing impairment due to terbinafine (LAMISIL, generics)
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Allergy to indacaterol (ONBREZ BREEZHALER)
|
| |
| |
e a-t IN THE INTERNET
|
| |
Company guide: information supplementing the spot-on story
|
| |